Introduction

vet007

Company name: Animax Ltd

Address: Shepherds Grove West

Stanton

Bury St Edmunds

Suffolk

IP31 2AR

Telephone: (01359) 252181

Fax: (01359) 252182

Email: products@animax-vet.com

Website: www.animax-vet.com

Presentation

Levasure 7.5% is a clear aqueous buffered solution of Levamisole Hydrochloride Ph. Eur. 7.5% w/v with a yellow colour and a slight sulphurous odour

Uses

Levasure 7.5% is a broad spectrum anthelmintic for the treatment and control of gastrointestinal and pulmonary nematode infections in cattle and sheep. Levasure 7.5% is highly effective against mature and developing immature stages of levamisole susceptible major stomach and bowel worm species including, Gastro-intestinal worms: Haemonchus spp; Ostertagia spp (except inhibited Ostertagia larvae in cattle); Nematodirus spp; Trichostrongylus spp; Cooperia spp; Oesophagostomum spp; Chabertia spp; Bunostomum spp; Lungworms: Dictyocaulus spp.

Levasure 7.5% is not effective against Type II Winter Scour.

Dosage and administration

Levasure 7.5% should be administered as an oral drench. Dosing should be carried out accurately, preferably using a gun system at a rate of 7.5 mg Levamisole hydrochloride per kg bodyweight.

Dosage Guide for Cattle: 1 ml Levasure 7.5% per 10 kg bodyweight.
Liveweight	Dose
50 kg (approx. 1 cwt)	5 ml
100 kg (approx 2 cwt)	10 ml
150 kg (approx 3 cwt)	15 ml
200 kg (approx 4 cwt)	20 ml
250 kg (approx. 5 cwt)	25 ml
300 kg (approx. 6 cwt)	30 ml
Cattle over 300 kg should be given a further 1 ml for each additional 10 kg bodyweight

Dosage Guide for Sheep: 0.5 ml Levasure 7.5% per 5 kg bodyweight.
Liveweight	Dose
10 kg (approx. 22 Ib)	1 ml
20 kg (approx, 44 Ib)	2 ml
30 kg (approx. 66 Ib)	3 ml
40 kg (approx. 88 Ib)	4 ml
50 kg (approx. 110 lb)	5 ml
60 kg (approx. 132 lb)	6 ml
Sheep over 60 kg should be given a further 0.5 ml for each additional 5 kg bodyweight.

Contra-indications, warnings, etc

Withdrawal periods

Animals must not be slaughtered for human consumption during treatment. Cattle and sheep may be slaughtered for human consumption only after 20 days from the last treatment.

This product should not be used in animals producing milk for human consumption.

Animals must not be treated within a period of 14 days before or after treatment with organophosphorus compounds or diethylcarbamazine citrate.

At normal therapeutic dosages side effects are rarely seen. Overdosage may occasionally result in the appearance of Cholinergic type symptoms such as salivation, muscular tremors and head shaking. They are more likely to be observed in cattle than in sheep.

Care should be taken to estimate accurately the bodyweight of animals to be treated before calculating the dosage. The product may be given to young, pregnant and lactating animals, but due regard must always be paid to the animal's physical condition and the presence of inter-current diseases.

Veterinary advice should be sought on appropriate dosing programmes and stock management to achieve adequate parasite control, and to reduce the likelihood of anthelmintic resistance developing and also if the product does not achieve the desired clinical effect, since other diseases, nutritional disturbances or anthelmintic resistance may be involved.

Operator warnings

When using do not eat, drink or smoke. Wash splashes from eyes and skin immediately. Take off immediately any contaminated clothing. Wash hands and exposed skin before meals and after work.

Levamisole can cause idiosyncratic reactions and serious blood disorders in a very small number of people. If symptoms such as dizziness, nausea, vomiting or abdominal discomfort are experienced when using this product, or sore mouth/throat or fever occur shortly afterwards, then medical advice should be sought immediately.

General precautions

For animal treatment only. Keep out of the reach of children.